Campylobacter Research Today is a free monthly online journal that collates and summarizes the latest research about Campylobacter, including details on food poisoning, infection, symptoms, treatment.

A linear model for managing the risk of antimicrobial resistance originating in food animals.

Bartholomew MJ, Vose DJ, Tollefson LR, Travis CC

FDA Center for Veterinary Medicine, 7500 Standish Place, Rockville, MD 20855, USA. mbarthol@cvm.fda.gov

A linear population risk model used by the U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) estimates the risk of human cases of campylobacteriosis caused by fluoroquinolone-resistant Campylobacter. Among the cases of campylobacteriosis attributed to domestically produced chicken, the fluoroquinolone resistance is assumed to result from the use of fluoroquinolones in poultry in the United States. Properties of the linear population risk model are contrasted with those of a farm-to-fork model commonly used for microbial risk assessments. The utility of the linear population model for the purpose for which it was used by CVM is discussed.

Published 24 March 2005 in Risk Anal, 25(1): 99-108.
Full-text of this article is available online (may require subscription).

© 2004-2008 Campylobacter Research Today. All Rights Reserved.